Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Attention deficit hyperactivity disorder
ADR ID BADD_A09509
ADR Hierarchy
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.04      Attention deficit and disruptive behaviour disorders
19.21.04.004      Attention deficit hyperactivity disorder
Description A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [MeSH]
MedDRA Code 10083622
MeSH ID D001289
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
ADD | ADDH | Attention deficit disorder | Attention deficit disorder of childhood | Attention deficit disorder of childhood with hyperactivity | Attention deficit disorder of childhood without mention of hyperactivity | Attention deficit-hyperactivity disorder | Attention deficit/hyperactivity disorder | Attention deficit/hyperactivity disorder NOS | Hyperactive child syndrome | Hyperkinesis of childhood with developmental delay | Hyperkinetic conduct disorder of childhood | Hyperkinetic syndrome | Hyperkinetic syndrome of childhood | Other specified manifestations of hyperkinetic syndrome of childhood | Overactive child | Syndrome hyperkinetic | Unspecified hyperkinetic syndrome of childhood | Hyperactivity syndrome aggravated | ADHD | ADHD, combined type | ADHD, predominantly hyperactive-impulsive type | ADHD, predominantly inattentive type | Attention deficit hyperactivity disorder | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorders with Hyperactivity | Attention Deficit Hyperactivity Disorders | Attention Deficit-Hyperactivity Disorder | Attention Deficit-Hyperactivity Disorders | Deficit-Hyperactivity Disorder, Attention | Deficit-Hyperactivity Disorders, Attention | Disorder, Attention Deficit-Hyperactivity | Disorders, Attention Deficit-Hyperactivity | Hyperkinetic Syndrome | Syndromes, Hyperkinetic | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention Deficit Disorders | Deficit Disorder, Attention | Deficit Disorders, Attention | Disorder, Attention Deficit | Disorders, Attention Deficit | Brain Dysfunction, Minimal | Dysfunction, Minimal Brain | Minimal Brain Dysfunction
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00023Acetaminophen0.000268%
BADD_D00129Amoxicillin0.000005%
BADD_D00165Aripiprazole0.000452%
BADD_D00180Atomoxetine0.001925%
BADD_D00356Carbamazepine0.000744%
BADD_D00471Ciprofloxacin--
BADD_D00475Citalopram0.000019%
BADD_D00501Clonazepam0.000045%
BADD_D00518Colchicine--
BADD_D00636Dextroamphetamine--
BADD_D00653Diclofenac0.000026%
BADD_D00749Efavirenz0.011010%
BADD_D00809Escitalopram0.000028%
BADD_D00812Eslicarbazepine acetate--
BADD_D00879Fentanyl--
BADD_D00898Finasteride0.001258%
BADD_D00932Fluoxetine0.000368%
BADD_D01003Ganciclovir--
BADD_D01046Guanfacine0.000381%
BADD_D01096Hydromorphone0.000278%
BADD_D01213Isotretinoin0.002959%
BADD_D01243Lamotrigine0.000911%
BADD_D01265Levetiracetam0.000397%
BADD_D01275Levofloxacin0.000063%
BADD_D01281Levonorgestrel--
BADD_D01330Lurasidone0.001672%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01405Methadone0.000265%
BADD_D01431Methylphenidate0.000876%
BADD_D01496Montelukast0.000175%
The 1th Page    1 2    Next   Last    Total 2 Pages